Accrol Group: Well placed for future growth

Accrol Group Holdings plc (LON:ACRL) has delivered a solid set of FY results, which were well flagged at the adjusted EBITDA level, but outperformed our adjusted EPS by 1.7%. We are maintaining our FY22 estimates, upgrading FY23 forecasts and introducing our FY24 numbers for the first time. We believe Accrol will emerge as a £45m+ EBITDA business with a self-funded papermill, and we believe the Group is well positioned to deliver strong growth in shareholder value from here.

  • Final results: Group revenues were +1.4% at £136.6m, and reflected volatile sales volumes impacted by changing consumer shopping habits during the pandemic. This was flagged in the trading update in May, with H2 volumes strengthening due to the impact of acquisitions. Whilst the total tissue market contracted by 1.3% YOY, Accrol’s market share has increased from 13.1% to 15.9% during the period. Gross margin progression is a key positive in these results, with underlying gross margin (excluding exceptional costs) +590bps to 28.6%. The progress made in margins was driven by productivity gains, underpinned by new systems and operating processes. Adjusted PBT of £9.1m is +93.6% YOY and 7.1% ahead of ZC estimate (£8.5m). Net debt of £14.6m (ex IFRS 16 leases) is in line with ZC expectations (£14.7m) and is £3.3m lower YOY, despite the £3.9m cash acquisition of Jon Dale. Today’s announcement also confirms the restoration of the dividend.
  • Outlook: Current trading for FY22 is in line with expectations, with an improving trend in sales MoM and YoY.Increased input costs, driven by pulp price inflation, are being mitigated through prompt pricing action. Significant investment is planned in wet wipes in FY22, which should drive material growth into FY23.  Longer term growth is backed by an acceleration in discounters planned new store openings. Overall, and with a self-funded paper mill in the offering, we believe Accrol is in a strong position to deliver significant shareholder value.
  • Forecasts: Our FY22E P&L forecasts are unchanged, with current trading in line with management expectations. FY22E net debt moves higher reflecting investment in working capital. FY23E revenue and PBT forecasts increase 2.2% and 3.2% respectively to reflect investment in automation and wet wipes which should drive growth beyond FY23E. FY24E numbers are introduced for the first time with EBITDA approaching £35m in line with our investment thesis.
  • Investment view: At current levels, Accrol Group trades on an FY22E PE of 10.5x, falling to 9.0x in FY23E, a material discount to its quoted peers. A re-rating towards peer average of 18-20x FY22E P/E would imply 78.2p -86.9p, representing upside of 72% to 91% versus current levels. Intrinsically, we believe the Group can generate revenue of c.£250m, with the addition of a paper mill driving gross margins towards 33% and EBITDA margin towards 18%. On this basis the Group could deliver EBITDA in excess of £45.0m, driving significant uplift in shareholder value.
Click to view all articles for the EPIC: ,
Or click to view the full company profile:
Facebook
Twitter
LinkedIn
Accrol Group Holdings plc

More articles like this

Accrol Group

UK Manufacturing industry shows growth and recovery in March

The UK’s manufacturing industry has returned to growth and is showing “tentative signs of recovery”, according to a closely-watched survey. Both output and new orders increased in March, while business optimism also hit an 11-month high,

Accrol Group

British manufacturing sees surge in sales and job creation

British manufacturing is witnessing a Brexit boost as sales rocket in the EU, Middle East and Far East, and the lifeblood of the UK economy flows once more. Major players in automotive, aerospace, construction, electrification, and

Accrol Group

Greenarc partnered with Accrol to install onsite EV chargers

Accrol Group Holdings plc (LON:ACRL) is the UK’s leading independent tissue converter, producing toilet tissue, kitchen towel, facial tissue and biodegradable wet wipes. The UK soft tissue market is worth £1.6bn with private label products comprising

Accrol Group

UK manufacturing industry sees £48.5bn productivity boost in 2023

The UK manufacturing industry achieved productivity improvements worth £48.5bn in 2023, according to analysis of ONS data by Fourjaw Manufacturing Analytics, a technology company that measures machine productivity. This represents an 8.6% increase on 2022 levels